Journal of the Korea Academia-Industrial cooperation Society (한국산학기술학회논문지)

The Korea Academia-Industrial cooperation Society (한국산학기술학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence and Management of Dyslipidemia, Hypertension, Diabetes Among Adults in Gangwon-do, Korea: the 2013-2014 KNHSP

강원도 성인의 이상지질혈증, 고혈압, 당뇨병의 유병률과 관리: 국가건강검진(2013-2014) 자료의 분석결과와 시사점

  • 장성옥 (한국건강관리협회) ;
  • 이종석 (한림대학교 경영학부, 한림경영연구소)
  • Received : 2016.11.17
  • Accepted : 2017.01.06
  • Published : 2017.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Dyslipidemia, hypertension, and diabetes are well-established risk factors for cardio-cerebrovascular disease (CVD). Although the prevalence of dyslipidemia among Korean adults is very high, its management is known to be poor. The aim of this study was to assess the prevalence, awareness, treatment, and control rates of dyslipidemia among adults aged 30 years and older in Gangwon-do, Korea. Analysis included 58,121 adults (29,123 males and 28,998 females) participating in the 2013-2014 Korea National Health Screening Program (KNHSP). Dyslipidemia was defined according to the treatment criteria rather than the diagnostic criteria in Korea. Therefore, high-low-density lipoprotein cholesterol (LDL)-cholesterolemia was deemed present in individuals with LDL-cholesterol levels that exceeded the appropriate risk-based threshold. The age-standardized prevalence was highest in dyslipidemia (32.5%), followed by hypertension (25.1%), and diabetes (9.4%). The awareness rate was 76.7% for hypertension and 74.7% for diabetes, but only 10.6% for dyslipidemia. The lowest patient treatment was found for dyslipidemia (9.4%). The control rate among those undergoing treatment was highest for hypertension (75.8), followed by dyslipidemia (63.3%), and diabetes (43.9%). The higher CVD-risk categories showed lower control rates of hyper-LDL-cholesterolemia. The prevalence of dyslipidemia was higher than hypertension and diabetes, but awareness and treatment rates were lower. Our findings indicate there is a wide gap between the prevalence of dyslipidemia and subsequent treatment, which suggests that effective strategies are required to improve dyslipidemia management. It would be worthwhile to strengthen the follow-up management of patients with dyslipidemia in the KNHSP, especially for the high risk group of CVD.

이상지질혈증, 고혈압, 그리고 당뇨병은 심뇌혈관질환의 주된 위험인자로서, 한국 성인의 이상지질혈증 유병률은 높지만 관리가 미흡하다는 문제점이 제기되어 왔다. 본 연구의 목적은 이상지질혈증에 초점을 두고 이러한 위험요인들의 유병률, 인지율, 치료율, 그리고 조절률을 조사하는 것이다. 이를 위해 한국건강관리협회 강원지부에서 2013년과 2014년에 국가건강검진을 받은 30세 이상의 성인 58,121명(남자 29,123명, 여자 28,998명)의 자료를 분석하였다. 이상지질혈증의 정의는 진단기준이 아닌, 이의 관리를 위한 치료기준을 따랐다. 즉 심뇌혈관질환 위험요인과 수준을 평가하여, 위험군에 따라 차등적인 LDL-콜레스테롤의 치료목표를 적용하였다. 연령 표준화된 유병률은 이상지질혈증이 32.5%로 가장 높았고, 그 다음으로 고혈압 25.1%, 당뇨병 9.4%의 순이었다. 유병자 기준 연령 표준화된 인지율은 고혈압 76.7%, 당뇨병 74.7%이었지만, 이상지질혈증은 10.6%에 불과했다. 유병자의 연령 표준화된 치료율은 고혈압 74.6%, 당뇨병 70.2%이었지만, 이상지질혈증은 9.4%로 가장 낮았다. 치료 받은 사람의 조절률은 고혈압이 75.8%로 가장 높았고, 그 다음으로 이상지질혈증 63.3%, 당뇨병 43.9%의 순이었다. 그리고 심뇌혈관질환 위험수준이 높은 집단일수록, 고LDL-콜레스테롤혈증의 조절률은 더 낮았다. 이상지질혈증의 유병률은 고혈압과 당뇨병보다 더 높았지만, 인지율과 치료율은 매우 낮은 수준이었다. 이러한 결과는 이상지질혈증 유병자들에 대한 관리 수준을 향상시키기 위한 효과적인 방안이 모색되어야 한다는 것을 제시한다. 이를 위해서는 이상지질혈증에 대한 현행 진단 위주의 국가건강검진체계를 치료 중심의 관리체계로 전환하고, 특히 심뇌혈관질환 고위험군에 대한 사후관리를 강화해야 한다.

Keywords

References

  1. Statistics Korea, "Annual report on the cause of death statistics", Daejeon: Statics Korea, 2016.
  2. R. Cooper, J. Cutler, P. Desvigne-Nickens, S. P. Fortmann, L. Friedman, R. Havlik, et al., "Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United State: findings of the national conference on cardiovascular disease prevention", Circulation, vol. 102, no. 25, pp. 3137-3147, 2000. DOI: https://doi.org/10.1161/01.CIR.102.25.3137
  3. A. S. Go, D. Mozaffarian, V. L. Roger, E. Benjamin, J. D. Berry, M. J. Blaha, et al., "Heart disease and stroke statistics-2014 update". Circulation, vol. 129. no. 3, e28-e292, 2014. DOI: https://doi.org/10.1161/01.cir.0000441139.02102.80
  4. T. Okamura, "Dyslipidemia and cardiovascular disease: a series of epidemiologic studies in Japanese population", Journal of Epidemiology, vol. 20, no. 4, pp. 259-265. 2010. DOI: https://doi.org/10.2188/jea.JE20100060
  5. Y. H. Jeong, S. J. Go, E. J. Kim, "A study on the effective chronic disease management", Seoul: Korea Institute for Health and Social Affairs, 2013.
  6. H. J. Kim, Y. Kim, Y. Cho, B. Jun, K. W. Oh, "Trends in the prevalence of major cardiovascular disease risk factors among Korean adult: Results from the Korea National Health and Nutrition Examination Survey", Internal Journal of Cardiology, vol. 174, no. 1, pp. 64-72, 2014. DOI: https://doi.org/10.1016/j.ijcard.2014.03.163
  7. Korean Society of Lipidology and Atherosclerosis, "Dyslipidemia Fact Sheet in Korea 2015", 2015.
  8. E. Ahn, D. W. Shin, H. Yang, J. M. Yun, S. H. Chun, B. Suh et al., "Treatment Gap in the National Health-screening Program in Korea: Claim-based Follow-up of Statin Use for Sustained Hypercholesterolemia", Journal of Korean Medical Science, vol. 30, no. 9, pp. 1266-1272, 2015. DOI: https://doi.org/10.3346/jkms.2015.30.9.1266
  9. Korea Centers for Disease Control and Prevention, "Korea Health Statistics 2013: National Korea National Health and Nutrition Survey (KNHANES VI-1)", 2014.
  10. E. Roh, S. H. Ko, H. S. Kwon, N. H. Kim, J. H. Kim, C. S. Kim, et al., "Prevalence and Management of Dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010", Diabetes & Metabolism Journal, vol. 37, no. 6, pp. 433-449, 2013. DOI: https://doi.org/10.4093/dmj.2013.37.6.433
  11. Committee for Guidelines for Management of Dyslipidemia, "2015 Korean Guidelines for Management of Dyslipidemia", Journal of Lipid and Atherosclerosis, vol. 4. no. 1, pp. 61-62, 2015. DOI: https://doi.org/10.12997/jla.2015.4.1.61
  12. W. T. Friedewald, R. I. Levy, D. S. Fredrickson, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clinical Chemistry, vol. 18, no. 6, pp. 499-502, 1972.
  13. World Health Organization, "The Asia-Pacific perspective: redefining obesity and its treatment", Genova: World Health Organization Western Pacific Regional Office, 2000.
  14. World Health Organization, "Definition, diagnosis and classification of diabetes mellitus and its complication", Geneva: World Health Organization, 2001.
  15. Korea Statistics, "2010 Population Census", Daejeon: Statics Korea, 2011.
  16. T. Gordon, W. P. Castelli, M. C. Hjortland, W. B. Kannel, T. R. Dawber, "High density lipoprotein as a protective factor against coronary heart disease: Framingham Study", The American Journal of Medicine, vol. 62, no. 5, pp. 707-714, 1977. DOI: https://doi.org/10.1016/0002-9343(77)90874-9
  17. S. O. Jang, J. S. Lee, "Prevalence and Management of Dyslipidemia Among Korean Adults: KNHANES 2010-2012", Journal of the Korea Academia-Industrial Cooperation Society, vol. 16, no. 11, pp.7978-7989, 2015. DOI: https://doi.org/10.5762/KAIS.2015.16.11.7978
  18. J. S. Lee, H. J. Son, O. H. Ryu, "Management Status of Cardiovascular Disease Risk Factors Focused on Dyslipidemia Among Korean Adults", Yonsei Medical Journal, Forthcoming.
  19. S. Dominic, "Diabetic Dyslipidemia: Form Evolving Pathophysiological Insight to Emerging Therapeutic Targets", Canadian Journal of Diabetes, vol. 37, no. 5, pp. 319-326, 2013. DOI: https://doi.org/10.1016/j.jcjd.2013.07.062
  20. Y. G. Cho, H. J. Song, B. J. Park, NCEA-9 Lipid Agents Research Group, "The comparison of guidelines for management for dyslipidemia and the appropriateness of them in Korea", Korean Journal of Family Medicine, vol. 31, no. 3, pp. 171-181, 2010. DOI: https://doi.org/10.4082/kjfm.2010.31.3.171
  21. J. M. Gaziano, T. A. Gaziano, "What's new with measuring cholesterol?", The Journal of the American Medical Association, vol. 310, no. 19, pp.2043-2044, 2013. DOI: https://doi.org/10.1001/jama.2013.282775
  22. D. Stainberg, "Thematic review series; the pathogenesis of atherosclerosis; an interpretive history of the cholesterol controversy, part III: mechanically defining the role of hyperlipidemia", Journal of Lipid Research, vol. 46, no. 10, pp. 2037-2051, 2005. DOI: https://doi.org/10.1194/jlr.R500010-JLR200
  23. J. Stamlar, D. Wentworth, J. D. Neaton, "Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)", JAMA, vol. 256, no. 20, pp. 2823-2828, 1986. DOI: https://doi.org/10.1001/jama.256.20.2823
  24. R. C. Turner, H. Millns, H. A. W. Neil, I. M. Stratton, S. E. Manley, D. R. Matthews et al,, "Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)", The British Medical Journal, vol. 316, no. 7134, pp. 823-828, 1998. DOI: https://doi.org/10.1136/bmj.316.7134.823
  25. S. O. Jang, J. S. Lee, "Friedewald-Estimated Versus Directly Measured LDL-Cholesterol: KNHANES 2009-2010", Journal of the Korea Academia-Industrial Cooperation Society, vol. 16, no. 8, pp.5492-5500, 2015. DOI: https://doi.org/10.5762/KAIS.2015.16.8.5492